Suppliers / Compounds & building blocks

Monte Rosa Therapeutics
Basel, Switzerland · monterosatx.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the supplier and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Monte Rosa Therapeutics is a biotechnology company developing targeted protein degradation medicines. It operates in Boston, Massachusetts and Basel, Switzerland, with a focus on cardiometabolic, inflammation, immunology, and oncology programs.
Their website has a general contact form; we send your quote request through it.
What they offer
Targeted protein degradation drug discovery
Discovers and develops medicines based on degrading disease-causing proteins, including previously undruggable targets.
Molecular glue discovery
Develops molecular glue approaches to enable targeted protein degradation for drug discovery programs.
Precision oncology program development
Advances oncology candidates including MRT-2359, described as a world’s first MGD for solid tumors.
Immunology program development
Advances immunology candidates including MRT-6160, described as a world’s first MGD for immunology.
Discovery and development of novel therapies
Progresses drug candidates from bench to clinic across multiple therapeutic areas.
What they work on
- Services
- Small molecule, Antibody
- Sites
- Boston, United States · Basel, Switzerland
- Address
- 321 Harrison Avenue, Suite 900 Boston, MA 02118 United States
- Founded
- 2018
Similar suppliers. 2bind Pharma Services, AAPharmaSyn, Aberjona Laboratories, Acellera
Found in a contract services directory. Listing built from monterosatx.com. Work here? Claim this listing.